Archives for June 9, 2009

← 2009

CBI targets “boom” in peptide outsourcing market

By Nick Taylor

Commonwealth Biotechnologies (CBI) is set to acquire China-based peptide manufacturer GL Biochem, which it believes will create a dominant force in the non-GMP segment of the market.

GSK grows in Asia vacc market

By Gareth Macdonald

UK drug major GSK has had a busy week in the Asia, signing an influenza vaccine manufacturing deal with China’s Shenzhen Neptunus Interlong Bio-Technique just days after it opened a new S$600m (EUR294m) production facility in Singapore.

FDA revises ICH Q8 guidance

By Nick Taylor

The FDA has revised its guidance on ICH Q8, adding an annex that clarifies the original document and adds the principles of quality by design (QbD).

TechTeam sharpens eClinical focus

By Nick Taylor

In response to eClinical opportunities TechTeam has established a global life sciences business unit, which it believes can grow “at an aggressive rate”.

Velesco adds clinical trial manufacturing to offering

By Gareth Macdonald

US contractor Velesco Pharmaceutical Services has leased a new clinical trial materials manufacturing facility in Kalamazoo, Michigan, extending its range of preclinical and early trial development services.